We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 2,269

CJEU rules on cross-border interim relief in patent proceedings
  • Fieldfisher LLP
  • European Union
  • October 16 2012

In the case of Solvay SA v Honeywell Fluorine Products Europe BV and others(Case C-61610 12 July 2012) the Court of Justice of the European Union (CJEU) has found that the rules regarding exclusive jurisdiction under the EU Jurisdiction Regulation (the "Regulation") do not prohibit courts of a member state granting cross-border interim injunctions in patent proceedings

Current issues in lifesciences
  • CMS Cameron McKenna
  • Czech Republic, European Union
  • January 11 2012

The lifescience sector is driven by development and innovation

Unified Patent Court agreement: Italy and Spain opt-out
  • A&L Goodbody
  • European Union
  • February 20 2013

This week saw 25 member states signing the Unified Patent Court Agreement in Brussels which represents the latest aspect towards achieving a new

Supplementary Protection Certificates on reformulations and new uses afer neurim: where do we go from here?
  • D Young & Co
  • European Union
  • March 1 2013

In 2012, the EU's Court of Justice (CJEU) gave a positive decision for the applicant in the Neurim Pharmaceuticals supplementary protection

AstraZeneca v European Commission, Case c-45710 P
  • White & Case LLP
  • European Union
  • December 10 2012

On 6 December 2012, the European Court of Justice upheld the judgment of the General Court, which found that AstraZeneca abused its dominant position on the market for proton pump inhibitors by misleading patent authorities and misusing the regulatory system in order to prevent generic competition against its anti-ulcer medicine, Losec (omeprazole), in certain markets

AstraZeneca judgment: don’t game the system
  • CMS Cameron McKenna
  • European Union
  • December 12 2012

In a long-awaited judgment dated 6 December 2012, the European Court of Justice (ECJ) has confirmed that certain brand protection strategies may infringe the EU competition rules

CJEU rejects Italian and Spanish challenges to the Council’s unitary patent decision
  • McDermott Will & Emery
  • European Union, Italy, Spain
  • April 30 2013

In Kingdom of Spain and Italian Republic v Council of the European Union Joined Cases C-27411 and C-29511, the Court of Justice of the European

Pharma: UE has exclusive competence over patentability
  • Nctm Studio Legale
  • European Union
  • September 30 2013

With its judgment rendered on July 18, 2013 (Case C-41411), the European Court of Justice (ECJ) held that the TRIPs (Agreement on Trade-Related

Significant stem cell decision from European Court
  • Rouse
  • European Union
  • December 18 2014

European Court approves patenting of embryonic stem cell technologies using unfertilised human ova Under the Biotech directive, the use of human

Unitary patent and Unified Patent Court - progress update
  • D Young & Co
  • European Union
  • June 12 2015

Following a comparatively quiet period in the first quarter of 2015, there has been a flurry of public activity in relation to both the Unitary